Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins

Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the limited anti-tumor effects, intratumor injection, and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Deliv
Hlavní autoři: Liu, Xiao-Qin, Xin, Hong-Yi, Lyu, Yan-Ning, Ma, Zhao-Wu, Peng, Xiao-Chun, Xiang, Ying, Wang, Ying-Ying, Wu, Zi-Jun, Cheng, Jun-Ting, Ji, Jia-Fu, Zhong, Ji-Xin, Ren, Bo-Xu, Wang, Xian-Wang, Xin, Hong-Wu
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2018
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282442/
https://ncbi.nlm.nih.gov/pubmed/30799657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1534895
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky